Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Current articles 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Acta Virologica Vol.62, No.2, p.191-195, 2018 |
||
Title: Antiviral effect of a derivative of isonicotinic acid enisamium iodide (FAV00A) against influenza virus | ||
Author: D. COCKING, J. CINATL, D. A. BOLTZ, X. PENG, W. JOHNSON, M. MUZZIO, O. SYARKEVYCH, G. KOSTYUK, A. GOY, L. MUELLER, V. I. MARGITICH | ||
Abstract: With only a single class of antiviral drugs existing for treatment of influenza (neuraminidase inhibitors), the search for novel effective compounds is urgently needed. We evaluated a low molecular mass compound, enisamium iodide (FAV00A), against influenza virus infections in primary differentiated normal human bronchial epithelial (NHBE) cells, and in ferrets. FAV00A (500 µg/ml) markedly inhibited influenza virus replication and reduced viral M-gene expression in NHBE cells. Treatment of ferrets with FAV00A (200 mg/kg once daily for 7 days) initiated 24 h after inoculation with 105 TCID50 of influenza A/Wisconsin/67/2005 (H3N2) virus resulted in a significant decrease in virus titers in the upper respiratory tract. Our data show that FAV00A exhibits an antiviral effect against influenza virus in NHBE cells and provides some benefits in a ferret model. Thus, further |
||
Keywords: antiviral agents; enisamium iodide; influenza virus; MDCK cells; NHBE cells; ferrets | ||
Published online: 07-Jun-2018 | ||
Year: 2018, Volume: 62, Issue: 2 | Page From: 191, Page To: 195 | |
doi:10.4149/av_2018_211 |
||
|
download file |
|